Viewing Study NCT04409132


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-03-20 @ 2:02 AM
Study NCT ID: NCT04409132
Status: COMPLETED
Last Update Posted: 2021-07-13
First Post: 2020-05-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
Sponsor: Rockwell Medical Technologies, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End Stage Renal Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacokinetics View